COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability
Not Applicable
Completed
- Conditions
- Sars-CoV-2 InfectionCOVID-19
- Interventions
- Device: Rapid SARS-CoV-2 Antigen Test
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- MP Biomedicals, LLC
- Target Recruit Count
- 99
- Registration Number
- NCT05584189
- Locations
- ๐บ๐ธ
EDP Biotech Corporation, Knoxville, Tennessee, United States
COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation
Not Applicable
Completed
- Conditions
- COVID-19SARS-CoV2 Infection
- Interventions
- Device: iCura COVID-19 Antigen Rapid Home TestDevice: RT-PCR Test
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- MP Biomedicals, LLC
- Target Recruit Count
- 332
- Registration Number
- NCT05584176
- Locations
- ๐บ๐ธ
Accel Research, DeLand, Florida, United States
๐บ๐ธDaniel Sarkis, Gainesville, Florida, United States
๐บ๐ธAccel Research Site St. Petersburg, Saint Petersburg, Florida, United States
MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study
Phase 4
Completed
- Conditions
- HTLV I Associated T Cell Leukemia LymphomaHTLV-I InfectionsHuman T-lymphotropic Virus 1HTLV I Associated MyelopathiesHuman T-lymphotropic Virus 2HTLV-II Infections
- Interventions
- Diagnostic Test: MP Diagnostics HTLV Blot 2.4
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2018-09-13
- Lead Sponsor
- MP Biomedicals, LLC
- Target Recruit Count
- 150
- Registration Number
- NCT03226119
- Locations
- ๐บ๐ธ
Qualtex Laboratories, San Antonio, Texas, United States
๐บ๐ธLABS, Inc., Philadelphia, Pennsylvania, United States
๐บ๐ธEastern Virginia Medical School (EVMS), Norfolk, Virginia, United States
Dual Algorithm Post Market Clinical Study
Completed
- Conditions
- Human T-lymphotropic Virus 2Human T-lymphotropic Virus 1HTLV I Associated T Cell Leukemia LymphomaHTLV-I InfectionsHTLV-II InfectionsHTLV I Associated Myelopathies
- Interventions
- Diagnostic Test: MP Diagnostics HTLV Blot 2.4
- First Posted Date
- 2017-05-09
- Last Posted Date
- 2017-06-12
- Lead Sponsor
- MP Biomedicals, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT03146013
- Locations
- ๐บ๐ธ
American Red Cross - National Testing Laboratory, Charlotte, North Carolina, United States
Evaluation of the MP Diagnostics HTLV Blot 2.4
- Conditions
- HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1Human T-lymphotropic Virus 2HTLV I Associated T Cell Leukemia LymphomaHTLV I Associated Myelopathies
- Interventions
- Other: CDPHL Algorithm
- First Posted Date
- 2011-11-08
- Last Posted Date
- 2011-11-08
- Lead Sponsor
- MP Biomedicals, LLC
- Target Recruit Count
- 600
- Registration Number
- NCT01467024
- Locations
- ๐บ๐ธ
LABS, Inc, St. Louis, Missouri, United States
๐บ๐ธCalifornia Department of Public Health, Richmond, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath